Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-20-054825
Filing Date
2020-11-23
Accepted
2020-11-23 06:05:40
Documents
84
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 6-K meso-6k_20200930.htm 6-K 4131117
  Complete submission text file 0001564590-20-054825.txt   16281660

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT meso-20200930.xml EX-101.INS 4743144
3 XBRL TAXONOMY EXTENSION SCHEMA meso-20200930.xsd EX-101.SCH 105593
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE meso-20200930_cal.xml EX-101.CAL 86219
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE meso-20200930_def.xml EX-101.DEF 271122
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE meso-20200930_lab.xml EX-101.LAB 573548
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE meso-20200930_pre.xml EX-101.PRE 465195
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 201334196
SIC: 2836 Biological Products, (No Diagnostic Substances)